Aethlon Medical Inc (NASDAQ:AEMD)’s traded shares stood at 0.7 million during the latest session, with the company’s beta value hitting 1.77. At the last check today, the stock’s price was $0.74, to imply an increase of 0.90% or $0.0 in intraday trading. The AEMD share’s 52-week high remains $1.85, putting it -150.0% down since that peak but still an impressive 67.57% since price per share fell to its 52-week low of $0.24. The company has a valuation of $10.36M, with an average of 0.93 million shares in intraday trading volume over the past 10 days and average of 3.37 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Aethlon Medical Inc (AEMD), translating to a mean rating of 2.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give AEMD a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.2.
Aethlon Medical Inc (NASDAQ:AEMD) trade information
After registering a 0.90% upside in the latest session, Aethlon Medical Inc (AEMD) has traded red over the past five days. The 5-day price performance for the stock is 6.02%, and -13.43% over 30 days. With these gigs, the year-to-date price performance is -13.72%. Short interest in Aethlon Medical Inc (NASDAQ:AEMD) saw shorts transact 0.29 million shares and set a 0.98 days time to cover.
Aethlon Medical Inc (AEMD) estimates and forecasts
Looking at statistics comparing Aethlon Medical Inc share performance against respective industry, we note that the company has outperformed competitors. Aethlon Medical Inc (AEMD) shares are 153.24% up over the last 6 months, with its year-to-date growth rate higher than industry average at 79.22% against -6.90%.
AEMD Dividends
Aethlon Medical Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Aethlon Medical Inc (NASDAQ:AEMD)’s Major holders
Aethlon Medical Inc insiders hold 0.54% of total outstanding shares, with institutional holders owning 3.09% of the shares at 3.11% float percentage. In total, 3.09% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Aethlon Medical Inc (AEMD) shares. Going by data provided on Nov 30, 2024 , Fidelity Extended Market Index Fund holds roughly 73.38 shares. This is just over 0.53% of the total shares, with a market valuation of $53930.0. Data from the same date shows that the other fund manager holds a little less at 21.22, or 0.15% of the shares, all valued at about 15599.0.
